Public Comment | Oncology Therapeutic Radiopharmaceuticals: Dosage Optimization During Clinical Development Guidance for Industry | October 20, 2025 Share
Public Comment | Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices | August 2, 2024 Share
White Paper | Expedited Development of Diagnostics for Therapies Targeting Rare Biomarkers or Indications | January 26, 2022 Share
White Paper | Friends-Alexandria 7th Annual Blueprint for Breakthrough Forum | Research and Reimbursement in the Age of Precision Medicine | September 14, 2018 Share
White Paper | Early Evaluation of Molecularly Targeted Therapies for Childhood and Adolescent Cancer | February 14, 2018 Share
White Paper | Trends in the Molecular Diagnosis of Lung Cancer: Results from an Online Market Research Survey | July 20, 2017 Share
White Paper | Conference on Clinical Cancer Research 2010 – Panel 4 | Using Patient-Initiated Study Participation in the Development of Evidence for Personalized Cancer Therapy | April 7, 2016 Share
White Paper | Conference on Clinical Cancer Research 2010 – Panel 1 | Adaptive Clinical Trials Designs for Simultaneous Testing of Matched Diagnostics and Therapeutics | April 7, 2016 Share
White Paper | Conference on Clinical Cancer Research 2011 – Panel 1 | Alternative Trial Designs Based on Tumor Genetics/Pathway Characteristics Instead of Histology | April 7, 2016 Share
White Paper | Friends/Alexandria Forum 2012 | Blueprint for Future Drug/Diagnostic Co-Development 2012: Pre-Forum Report – Considerations for the successful co-development of targeted cancer therapies and companion diagnostics | April 7, 2016 Share
